Flybridge Capital expanding New York office
"Over the past five years, we've been spending time increasingly in New York, and we have several portfolio companies there now," says Aronoff, mentioning startups like 10Gen, a database company, and 33Across, in advertising technology. "Our deal flow in New York has really risen, and for the past couple years we've been holding one of our partner meetings every month in New York." (Aronoff adds that several of Flybridge's Boston-based portfolio companies, like Dataxu, also have sales and marketing offices in Manhattan.)
While the New York tech scene in the late 1990s may have "turned out to be a mirage," Aronoff contends that this time, it's different: "It's a really interesting ecosystem of entrepreneurs, and we're seeing things that are keeping us interested."
The Flybridge office is in SoHo, not far from where the TechStars New York accelerator program is located.
(As an aside: well worth a read is this recent blog post from Jeffrey Bussgang, a colleague of Aronoff's at Flybridge, which compares the recent IPO and M&A track records of New York and Boston.)

The Hive | Local Innovation News


Departing Zipcar CEO to be CoachUp director
On Facebook


Subscribe via e-mail

More from Scott
about the blogger
About Scott Kirsner Scott Kirsner was part of the team that launched Boston.com in 1995, and has been writing a column for the Globe since 2000. His work has also appeared in Wired, Fast Company, The New York Times, BusinessWeek, Newsweek, and Variety. Scott is also the author of the books "Fans, Friends & Followers" and "Inventing the Movies," was the editor of "The Convergence Guide: Life Sciences in New England," and was a contributor to "The Good City: Writers Explore 21st Century Boston." Scott also helps organize several local events on entrepreneurship, including the Nantucket Conference and Future Forward. Here's some background on how Scott decides what to cover, and how to pitch him a story idea.
Events
May 16 & 17: Convergence Forum on Life Sciences
Speakers from Bristol-Myers, Millennium Pharmaceuticals, and Biogen Idec talk about the next ten years of the biopharma business. Plus, journalist David Ewing Duncan on radical life extension. (I'm hosting.)
May 22: MIT Sloan CIO Symposium
Chief information officers from Guess, Haemonetics, Intel and other companies talk discuss "architecting the enterprise of the future."
June 25: TEDxBoston
The oldest and biggest of the locally-organized TED events is back, at the Seaport World Trade Center. Tickets are free, but tough to get. Also streams on the web and airs on WBUR.






